BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 90 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $342,000 | -37.8% | 40,700 | -14.6% | 0.01% | -36.4% |
| Q3 2017 | $550,000 | +16.0% | 47,650 | +17.4% | 0.01% | 0.0% |
| Q2 2017 | $474,000 | +7.2% | 40,600 | +13.2% | 0.01% | 0.0% |
| Q1 2017 | $442,000 | -10.0% | 35,850 | -0.6% | 0.01% | 0.0% |
| Q4 2016 | $491,000 | +16266.7% | 36,050 | +16667.4% | 0.01% | – |
| Q3 2015 | $3,000 | -25.0% | 215 | 0.0% | 0.00% | – |
| Q2 2015 | $4,000 | – | 215 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,051,441 | $1,356,000 | 0.23% |
| X-Square Capital, LLC | 199,791 | $258,000 | 0.15% |
| Nikko Asset Management Americas, Inc. | 2,300,682 | $2,968,000 | 0.05% |
| SPHERA FUNDS MANAGEMENT LTD. | 400,000 | $516,000 | 0.04% |
| Baker Brothers Advisors | 2,677,818 | $3,454,000 | 0.02% |
| SHUFRO ROSE & CO LLC | 129,417 | $167,000 | 0.02% |
| ARK Investment Management | 417,433 | $538,000 | 0.01% |
| ALGERT GLOBAL LLC | 36,806 | $47,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 352,465 | $455,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 66,472 | $86,000 | 0.01% |